In-depth exploration of public anger towards the American health care system throughout history, potential for change, and Hollywood's portrayal of health insurance-related events.
KFF Health News
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A systematic review of 439 studies reveals high-quality evidence supporting biologic therapies and defined treatment targets for systemic lupus erythematosus, with anifrolumab and belimumab showing superior efficacy to standard care in extrarenal disease.
AbbVie's Humira retains over 80% of patients despite nine lower-priced biosimilars entering the market, raising concerns about the viability of the biosimilar industry, which faces regulatory and market access challenges.